Metsera, Inc. (NASDAQ:MTSR – Free Report) – Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Metsera in a report issued on Thursday ...

Cantor Fitzgerald currently has a “Overweight” rating and a $46.00 price objective on the stock. The consensus estimate for Sanara MedTech’s current full-year earnings is ($1.10) per share ...

(Reuters) - Analysts at Cantor Fitzgerald, formerly headed by the Trump administration's Secretary of Commerce Howard Lutnick, called for the dismissal of Secretary of Health and Human Services ...

Cantor Fitzgerald biotech analysts slammed the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., calling on the Trump administration to “re-evaluate” his role after a ...

Cantor Fitzgerald did not immediately respond to Reuters' request for a comment. The ouster of Marks led to a decline in biotech and vaccine stocks on Monday. The SPDR S&P Biotech ETF closed down ...

On Tuesday, Cantor Fitzgerald analyst Eric Schmidt maintained an Overweight rating on Immatics (NASDAQ:IMTX), whose shares have declined nearly 60% over the past six months. According to ...

On Monday, Cantor Fitzgerald reaffirmed its positive stance on Archer Aviation Inc. (NYSE: NYSE:ACHR) by maintaining an Overweight rating and a $13.00 price target, representing a significant ...

(Reuters) - Analysts at Cantor Fitzgerald, formerly headed by the Trump administration's Secretary Of Commerce Howard Lutnick, called for the dismissal of Secretary of Health and Human Services Robert ...

Sprott Asset Management LP (“Sprott Asset Management”), a subsidiary of Sprott Inc., on behalf of the Sprott Physical Platinum and Palladium Trust (NYSE: ...